These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 27150062
1. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis. Li Q, Liu F, Zhang Y, Fu L, Wang C, Chen X, Guan S, Meng X. Oncotarget; 2016 Jun 07; 7(23):34520-31. PubMed ID: 27150062 [Abstract] [Full Text] [Related]
2. Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma. Narita K, Matsuda Y, Seike M, Naito Z, Gemma A, Ishiwata T. Int J Oncol; 2014 Apr 07; 44(4):1118-30. PubMed ID: 24481417 [Abstract] [Full Text] [Related]
5. Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer. Wu Y, Du X, Xue C, Li D, Zheng Q, Li X, Chen H. Med Oncol; 2013 Dec 07; 30(4):737. PubMed ID: 24126941 [Abstract] [Full Text] [Related]
9. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma. Cui Y, Cui CA, Yang ZT, Ni WD, Jin Y, Xuan YH. Exp Mol Pathol; 2017 Apr 07; 102(2):347-353. PubMed ID: 28286162 [Abstract] [Full Text] [Related]
13. Nestin is significantly associated with the overall survival of nonsmall cell lung cancer: A meta-analysis. Zhang D, Wang J. J Cancer Res Ther; 2020 Apr 07; 16(4):800-803. PubMed ID: 32930121 [Abstract] [Full Text] [Related]
15. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis. Yang SL, Ren QG, Wen L, Hu JL. J Huazhong Univ Sci Technolog Med Sci; 2016 Jun 07; 36(3):321-327. PubMed ID: 27376798 [Abstract] [Full Text] [Related]
16. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2. Brcic L, Sherer CK, Shuai Y, Hornick JL, Chirieac LR, Dacic S. Am J Clin Pathol; 2012 Nov 07; 138(5):712-8. PubMed ID: 23086772 [Abstract] [Full Text] [Related]
18. Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers. Ryuge S, Sato Y, Nagashio R, Hiyoshi Y, Katono K, Igawa S, Nakashima H, Shiomi K, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Masuda N. PLoS One; 2017 Nov 07; 12(3):e0173886. PubMed ID: 28358810 [Abstract] [Full Text] [Related]
19. Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation. Cai YR, Zhang HQ, Qu Y, Mu J, Zhao D, Zhou LJ, Yan H, Ye JW, Liu Y. Oncol Rep; 2011 Oct 07; 26(4):877-85. PubMed ID: 21687954 [Abstract] [Full Text] [Related]
20. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease. Toschi L, Finocchiaro G, Nguyen TT, Skokan MC, Giordano L, Gianoncelli L, Perrino M, Siracusano L, Di Tommaso L, Infante M, Alloisio M, Roncalli M, Scorsetti M, Jänne PA, Santoro A, Varella-Garcia M. PLoS One; 2014 Oct 07; 9(4):e95303. PubMed ID: 24736592 [Abstract] [Full Text] [Related] Page: [Next] [New Search]